company background image
2082 logo

Wanbangde Pharmaceutical Holding Group SZSE:002082 Stock Report

Last Price

CN¥5.05

Market Cap

CN¥3.1b

7D

1.8%

1Y

-40.4%

Updated

05 Apr, 2024

Data

Company Financials

Wanbangde Pharmaceutical Holding Group Co., Ltd.

SZSE:002082 Stock Report

Market Cap: CN¥3.1b

2082 Stock Overview

Wanbangde Pharmaceutical Holding Group Co, Ltd.

2082 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends3/6

Wanbangde Pharmaceutical Holding Group Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Wanbangde Pharmaceutical Holding Group
Historical stock prices
Current Share PriceCN¥5.05
52 Week HighCN¥8.64
52 Week LowCN¥3.70
Beta0.68
1 Month Change2.02%
3 Month Change-21.22%
1 Year Change-40.45%
3 Year Change-59.34%
5 Year Change-58.61%
Change since IPO23.36%

Recent News & Updates

Recent updates

Shareholder Returns

2082CN PharmaceuticalsCN Market
7D1.8%0.8%1.7%
1Y-40.4%-13.0%-15.8%

Rendite im Vergleich zur Industrie: 002082 unter dem Niveau der Branche CN Pharmaceuticals , die im vergangenen Jahr eine Rendite von -18.3% erzielte.

Rendite vs. Markt: 002082 hinter dem Markt CN zurück, der im vergangenen Jahr eine Rendite von -22 erzielte.

Price Volatility

Is 2082's price volatile compared to industry and market?
2082 volatility
2082 Average Weekly Movement7.3%
Pharmaceuticals Industry Average Movement7.1%
Market Average Movement8.3%
10% most volatile stocks in CN Market11.6%
10% least volatile stocks in CN Market5.2%

Stabiler Aktienkurs: 002082Der Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: 002082Die wöchentliche Volatilität (6%) ist im vergangenen Jahr stabil geblieben.

About the Company

FoundedEmployeesCEOWebsite
19851,569Shouming Zhaohttps://www.wepon.com.cn

Wanbangde Pharmaceutical Holding Group Co., Ltd. beschäftigt sich mit der Forschung und Entwicklung, der Produktion und dem Verkauf von traditioneller chinesischer Medizin, chemischen Rohstoffen und chemischen Präparaten in China und international. Das Unternehmen ist in den Segmenten Produktion und Verkauf von Arzneimitteln sowie Produktion und Verkauf von medizinischen Geräten und persönlicher Ausrüstung tätig.

Wanbangde Pharmaceutical Holding Group Co., Ltd. Fundamentals Summary

How do Wanbangde Pharmaceutical Holding Group's earnings and revenue compare to its market cap?
2082 fundamental statistics
Market capCN¥3.09b
Earnings (TTM)-CN¥60.49m
Revenue (TTM)CN¥1.62b

1.9x

P/S Ratio

-51.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2082 income statement (TTM)
RevenueCN¥1.62b
Cost of RevenueCN¥871.77m
Gross ProfitCN¥748.93m
Other ExpensesCN¥809.43m
Earnings-CN¥60.49m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 20, 2024

Earnings per share (EPS)-0.099
Gross Margin46.21%
Net Profit Margin-3.73%
Debt/Equity Ratio40.2%

How did 2082 perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

-123%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.